trafermin: Clinical Trials

4 trials of trafermin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 34Completed 4

Follow trafermin: new trials by email Literature Review of trafermin trials Research Report on trafermin

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The TRAfermin in Neuropathic Diabetic Foot Ulcer Study - Northern Europe The TRANS-North Study
Trafermin 0.01% spray - Diabetic Foot Ulcer of Neuropathic Origin
Phase 3CompletedOlympus Biotech Corporation2072010-12-012014-08-05
The TRAfermin in Neuropathic Diabetic Foot Ulcer Study - Southern Europe The TRANS-South Study
Trafermin 0.01% spray - Diabetic Foot Ulcer of Neuropathic Origin
Phase 3CompletedOlympus Biotech Corporation2012010-11-012014-08-05
A Study to Assess the Safety of Using Fibroblast Growth Factor-2 With Periodontal Surgery in Japan (Phase 3)
Trafermin - Periodontitis
Phase 3CompletedKaken Pharmaceutical252009-11-012013-10-21
Phase 3 Clinical Trial of Periodontal Tissue Regeneration Using Fibroblast Growth Factor-2(Trafermin)
Trafermin (genetical recombination), Placebo - Periodontitis, Alveolar Bone Loss
Phase 3CompletedKaken Pharmaceutical3282008-08-012012-06-15

Conditions studied

Diabetic Foot (2)  ·  Periodontitis (2)  ·  Wounds and Injuries (2)  ·  Alveolar Bone Loss (1)  ·  Periodontal Attachment Loss (1)

Sponsors

Kaken Pharmaceutical (2)  ·  Olympus Biotech Corporation (2)

Countries

Hungary (2)  ·  Japan (2)  ·  Belgium (1)  ·  Bulgaria (1)  ·  Croatia (1)  ·  Czechia (1)  ·  Denmark (1)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Slovakia (1)  ·  Sweden (1)

Top investigators

Chikara Ieda (2)  ·  Jean-Charles Kerihuel, MD (2)

Results publications

PMID 18596969